Natixis Advisors LLC Invests $485,000 in Oscar Health, Inc. (NYSE:OSCR)

Natixis Advisors LLC bought a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 36,115 shares of the company's stock, valued at approximately $485,000.

A number of other institutional investors have also recently made changes to their positions in the business. Arizona State Retirement System increased its position in Oscar Health by 3.1% during the fourth quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock valued at $644,000 after acquiring an additional 1,454 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Oscar Health by 9.2% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company's stock worth $561,000 after purchasing an additional 2,236 shares during the period. KBC Group NV grew its holdings in Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after purchasing an additional 2,555 shares during the last quarter. PNC Financial Services Group Inc. raised its position in Oscar Health by 20.5% in the 4th quarter. PNC Financial Services Group Inc. now owns 17,896 shares of the company's stock worth $241,000 after purchasing an additional 3,040 shares during the period. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its position in Oscar Health by 28.2% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 21,968 shares of the company's stock worth $295,000 after purchasing an additional 4,838 shares during the period. Institutional investors own 75.70% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of research firms have recently commented on OSCR. Jefferies Financial Group started coverage on Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 target price on the stock. Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $20.21.

Oscar Health Trading Down 1.2 %

OSCR traded down $0.17 during trading on Monday, hitting $13.14. 3,910,568 shares of the stock were exchanged, compared to its average volume of 3,758,802. Oscar Health, Inc. has a 1 year low of $12.43 and a 1 year high of $23.79. The firm has a market cap of $3.29 billion, a price-to-earnings ratio of -656.42 and a beta of 1.75. The firm has a 50 day simple moving average of $14.85 and a 200 day simple moving average of $16.00. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.